Evidence map›Paper›PMID 25427064›Full record

ArticlePloS one2014

Initiation of electron transport chain activity in the embryonic heart coincides with the activation of mitochondrial complex 1 and the formation of supercomplexes.

Gisela Beutner, Roman A Eliseev, George A Porter

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Complex II ambiguities-FADHThe Journal of biological chemistry · 2024
    Review
  7. Article
  8. The critical role of cardiolipin in metazoan differentiation, development, and maturation.Developmental dynamics : an official publication of the American Association of Anatomists · 2023
    Review
  9. Why Don't More Mitochondrial Diseases Exhibit Cardiomyopathy?Journal of cardiovascular development and disease · 2023
    Article
  10. Mitochondrial Permeability Transition in Stem Cells, Development, and Disease.Advances in experimental medicine and biology · 2023
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. The new role of FExperimental neurology · 2020
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Gisela BeutnerUniversity of Rochester Medical Center, Department of Pediatrics, Division of Cardiology, 601 Elmwood Ave., Box 631, Rochester, New York 14642, United States of America.
Roman A EliseevCenter for Musculoskeletal Research, University of Rochester, 601 Elmwood Ave., Rochester, New York 14642, United States of America.
George A PorterUniversity of Rochester Medical Center, Department of Pediatrics, Division of Cardiology, 601 Elmwood Ave., Box 631, Rochester, New York 14642, United States of America.
University of Rochester Medical Center · USUniversity of Rochester · US

Funding

The University of Rochester's Clinical and Translational Science InstituteUL1TR000042 · NCATS · UNIVERSITY OF ROCHESTER · PI BENNETT, NANCY M, KIEBURTZ, KARL D. · 2012 to 2015
$14.4M
The University of Rochester Clinical and Translational Science InstituteKL2TR000095 · NCATS · UNIVERSITY OF ROCHESTER · PI BENNETT, NANCY M, KIEBURTZ, KARL D. · 2012 to 2015
$1.7M
Mechanism of Mitochondrial Dysfunction in Mesenchymal Stem Cells During AgingK01AR064610 · NIAMS · UNIVERSITY OF ROCHESTER · PI ELISEEV, ROMAN · 2013 to 2015
$308k
NCATS NIH HHS KL2 TR000095NCATS NIH HHS UL1 TR000042NIAMS NIH HHS 5K01 AR064610NIAMS NIH HHS K01 AR064610
6 · The paper itself

Abstract

Mitochondria provide energy in form of ATP in eukaryotic cells. However, it is not known when, during embryonic cardiac development, mitochondria become able to fulfill this function. To assess this, we measured mitochondrial oxygen consumption and the activity of the complexes (Cx) 1 and 2 of the electron transport chain (ETC) and used immunoprecipitation to follow the generation of mitochondrial supercomplexes. We show that in the heart of mouse embryos at embryonic day (E) 9.5, mitochondrial ETC activity and oxidative phosphorylation (OXPHOS) are not coupled, even though the complexes are present. We show that Cx-1 of the ETC is able to accept electrons from the Krebs cycle, but enzyme assays that specifically measure electron flow to ubiquinone or Cx-3 show no activity at this early embryonic stage. At E11.5, mitochondria appear functionally more mature; ETC activity and OXPHOS are coupled and respond to ETC inhibitors. In addition, the assembly of highly efficient respiratory supercomplexes containing Cx-1, -3, and -4, ubiquinone, and cytochrome c begins at E11.5, the exact time when Cx-1 becomes functional activated. At E13.5, ETC activity and OXPHOS of embryonic heart mitochondria are indistinguishable from adult mitochondria. In summary, our data suggest that between E9.5 and E11.5 dramatic changes occur in the mitochondria of the embryonic heart, which result in an increase in OXPHOS due to the activation of complex 1 and the formation of supercomplexes.

Indexed as

Gene Expression Regulation, DevelopmentalAge FactorsAnimalsElectron TransportElectron Transport Complex IElectron Transport Complex IIElectron Transport Complex IIIElectron Transport Complex IVEmbryo, MammalianMiceMice, Inbred C57BLMitochondria, HeartMitochondrial MembranesMyocardiumOxidative PhosphorylationProtein MultimerizationElectron Transport Complex IElectron Transport Complex IIElectron Transport Complex IIIElectron Transport Complex IV

Identifiers

PMID25427064
PMCPMC4245138
OpenAlexW2050099115

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.